Jon Marc Wigginton's Net Worth

$3.7 Million

Estimate Recalculated Nov 8, 2024 04:40PM EST

Who is Jon Marc Wigginton?

Jon Marc Wigginton has an estimated net worth of $3.7 Million. This is based on reported shares across multiple companies, which include MACROGENICS INC, Cullinan Management, Inc., SUTRO BIOPHARMA, INC., and Checkmate Pharmaceuticals, Inc..

SEC CIK

Jon Marc Wigginton's CIK is 0001587487

Past Insider Trading and Trends

2015 was Jon Marc Wigginton's most active year for acquiring shares with 7 total transactions. Jon Marc Wigginton's most active month to acquire stocks was the month of September. 2015 was Jon Marc Wigginton's most active year for disposing of shares, totalling 14 transactions. Jon Marc Wigginton's most active month to dispose stocks was the month of September. 2017 saw Jon Marc Wigginton paying a total of $1,550,275.00 for 102,500 shares, this is the most they've acquired in one year. In 2016 Jon Marc Wigginton cashed out on 110,000 shares for a total of $1,634,900.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

MACROGENICS INC (MGNX) Snapshot price: $3.1701

Sr VP, Clinical Dev. & CMO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 20
Form 4
—
0
—
—
0
Feb 21
Form 4
—
0
—
—
0
Mar 2
Form 4
-36.90%
-11.07K
$23.46
-$259,702.20
18.93K
Feb 26
Form 4
—
0
$12.35
-$76,500.00
30K
Scheduled
Jan 16 - Jan 17
Form 4
—
0
$12.35
-$76,500.00
30K
Scheduled
Nov 21
Form 4
—
0
$12.35
-$153,000.00
30K
Scheduled
Oct 25
Form 4
—
0
$12.35
-$76,500.00
30K
Scheduled
Jun 5
Form 4
—
0
$12.35
-$229,500.00
30K
Scheduled
Apr 19
Form 4
—
0
—
—
0
Feb 15
Form 4/A
—
0
$17.02
-$246,400.00
0
Scheduled
Oct 3
Form 4
—
0
$17.02
-$246,400.00
0
Scheduled
Oct 3
Form 4
—
0
$17.74
-$521,600.00
0
Scheduled
Aug 1
Form 4
—
0
$15.96
-$112,600.00
0
Scheduled
Jul 1
Form 4
∞
30K
—
—
30K
Feb 25
Form 4
—
0
$17.17
-$249,400.00
0
Scheduled
Jan 4
Form 4
—
0
—
—
0
Dec 18
Form 4/A
—
0
$12.91
-$82,050.00
0
Scheduled
Oct 1
Form 4/A
—
0
$20.93
-$324,500.00
0
Scheduled
Aug 3
Form 4
—
0
$12.91
-$82,050.00
0
Scheduled
Oct 1
Form 4
—
0
$20.93
-$324,500.00
0
Scheduled
Aug 3
Form 4
—
0
$20.93
-$162,250.00
0
Scheduled
Jul 1
Form 4
—
0
$17.78
-$130,800.00
0
Scheduled
Apr 1 - Apr 1
Form 4
—
0
$17.87
-$131,700.00
0
Scheduled
Feb 2
Form 4
—
0
—
—
0
Dec 12
Form 4
—
0
$12.59
-$78,900.00
0
Scheduled
Oct 1
Form 4
—
0
$12.61
-$79,100.00
0
Scheduled
Aug 18
Form 3
—
0
—
—
0
No matching records found

Cullinan Management, Inc. (CGEM) Snapshot price: $17.98

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 7
Form 3
—
0
—
—
0
No matching records found

SUTRO BIOPHARMA, INC. (STRO) Snapshot price: $4.12

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
Nov 30
Form 3
—
0
—
—
0
No matching records found

Checkmate Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
Jan 30
Form 3
—
0
—
—
0
No matching records found